The LAMEA hyaluronic acid-based dermal fillers market Growth, Size, Industry RepPosted by Avinash on February 12th, 2020 The LAMEA hyaluronic acid-based dermal fillers market is estimated to grow at a CAGR of 7.4% during the forecast period. RoW countries include Brazil, Mexico and Colombia, Saudi Arabia and the United Arab Emirates (UAE). RoW dermal fillers market is estimated to grow significantly during the forecast period owing to the rising demand for non-surgical procedures coupled with the rising availability of filler options available in the Brazilian market. As a result, the companies are looking to expand the availability of their dermal fillers in these countries. For instance, in January 2018, Sinclair Pharma plc announced that it has received regulatory approval of Ellansé by ANVISA in Brazil. Brazil is considered as one of the major aesthetic dermatology markets with a considerable rise in the injectable procedures reported in 2017. Request a free sample of our report The LAMEA hyaluronic acid-based dermal fillers market: https://www.omrglobal.com/request-sample/lamea-hyaluronic-acid-based-dermal-fillers-market This is representing a significant demand for non-surgical cosmetic procedures in these countries. For instance, as per ISAPS, in Brazil, the number of injectable procedures was 677,765 in 2017, whereas, in Columbia, it was 125,350 in 2017. Due to such a rise in injectable procedures, a significant availability of plastic surgeons has been witnessed in 2017. For instance, as per the ISAPS, in 2017, the estimated number of plastic surgeons in Brazil was 5,500, while, the estimated number of plastic surgeons in Colombia was 1,000. The demand for this injectable procedure is anticipated to grow significantly in the region coupled with increasing disposable income across the countries, such as Saudi Arabia and UAE, which in turn, will likely drive the demand for dermal filler treatment in the region. The LAMEA hyaluronic acid-based dermal fillers market can be segmented based on application and end-users. Based on the application, the market is classified into face-lift, lip treatment/enhancement, facial line correction treatment, and other applications. Based on end-user, the market is segmented into dermatology clinics and hospitals. Among types, the calcium hydroxylapatite is projected to exhibit a significant growth rate in the market due to technology advancement and new product development. A full report of The LAMEA hyaluronic acid-based dermal fillers markethttps://www.omrglobal.com/industry-reports/lamea-hyaluronic-acid-based-dermal-fillers-market Key players operating in the LAMEA hyaluronic acid-based dermal fillers market include Allergan PLC, Galderma Laboratories, L.P., Merz Pharmaceuticals GmbH, Cynosure LLC, Prollenium Medical Technologies, Inc., and Teoxane SA. These companies adopt various strategies such as partnership & collaborations, finding a new market or product innovations in their core competency in order to stay competitive in the market. For instance, in November 2018, Galderma Laboratories, L.P. received an FDA approval for ‘Restylane Lyft’, a hyaluronic acid dermal filler used for cheek augmentation and age-related face contour deficiencies. Market Segmentation LAMEA Hyaluronic Acid-based Dermal Fillers Market by Application
LAMEA Hyaluronic Acid-based Dermal Fillers Market by End-User
REGIONAL ANALYSIS
COMPANY PROFILES
About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. Media Contact: Like it? Share it! More by this author |